Bionano Genomics, INC Form 4 insider transactions

NASDAQ
Mark Oldakowski, Chief Operating Officer of Bionano Genomics, reports the withholding of 1,229 shares of common stock to cover tax obligations related to a vested RSU award.
NASDAQ
Bionano Genomics CEO R. Erik Holmlin reports the withholding of 3,073 shares to cover tax obligations related to vested RSUs.
NASDAQ
Jonathan V. Dixon, General Counsel of Bionano Genomics, reports the withholding of 402 shares to cover tax obligations related to a vested RSU award.